AU2002228745A1 - Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma - Google Patents

Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma

Info

Publication number
AU2002228745A1
AU2002228745A1 AU2002228745A AU2874502A AU2002228745A1 AU 2002228745 A1 AU2002228745 A1 AU 2002228745A1 AU 2002228745 A AU2002228745 A AU 2002228745A AU 2874502 A AU2874502 A AU 2874502A AU 2002228745 A1 AU2002228745 A1 AU 2002228745A1
Authority
AU
Australia
Prior art keywords
antibodies
production
directed against
interferon gamma
ligands directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002228745A
Inventor
Eric O. Long
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RAJAGOPALAN SUMATI
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2002228745A1 publication Critical patent/AU2002228745A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
AU2002228745A 2000-10-23 2001-10-23 Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma Abandoned AU2002228745A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24241900P 2000-10-23 2000-10-23
US60/242,419 2000-10-23
PCT/US2001/046098 WO2002034290A2 (en) 2000-10-23 2001-10-23 Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma

Publications (1)

Publication Number Publication Date
AU2002228745A1 true AU2002228745A1 (en) 2002-05-06

Family

ID=22914715

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002228745A Abandoned AU2002228745A1 (en) 2000-10-23 2001-10-23 Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma

Country Status (3)

Country Link
US (2) US7435801B2 (en)
AU (1) AU2002228745A1 (en)
WO (1) WO2002034290A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10261223A1 (en) * 2002-12-20 2004-07-08 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Increasing the immune response through substances that influence the function of natural killer cells
EP2292264A3 (en) 2003-07-24 2012-12-19 Innate Pharma Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
EP2633866A3 (en) * 2003-10-17 2013-12-18 Novo Nordisk A/S Combination therapy
PL1836225T3 (en) * 2005-01-06 2012-05-31 Novo Nordisk As Kir-binding agents and methods of use thereof
JP5840494B2 (en) 2008-10-02 2016-01-06 エマージェント プロダクト デベロップメント シアトル， エルエルシー Multi-target binding protein of CD86 antagonist
TW201829463A (en) 2016-11-18 2018-08-16 瑞士商赫孚孟拉羅股份公司 Anti-hla-g antibodies and use thereof
AR114789A1 (en) 2018-04-18 2020-10-14 Hoffmann La Roche ANTI-HLA-G ANTIBODIES AND THE USE OF THEM
AR115052A1 (en) 2018-04-18 2020-11-25 Hoffmann La Roche MULTI-SPECIFIC ANTIBODIES AND THE USE OF THEM
JP7326584B2 (en) 2020-12-17 2023-08-15 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト Anti-HLA-G antibody and use thereof
EP4347635A2 (en) * 2021-05-26 2024-04-10 Board of Regents, The University of Texas System Chimeric antigen receptor to target hla-g-positive cancers
AU2022291384A1 (en) * 2021-06-09 2024-01-25 Serotiny, Inc. Synthetic receptor for conditional activation of immune cells
CN117448412A (en) * 2022-07-26 2024-01-26 中山大学孙逸仙纪念医院 CD158d molecule, neutralizing antibody and application

Also Published As

Publication number Publication date
US7435801B2 (en) 2008-10-14
US20030232051A1 (en) 2003-12-18
US20100255507A1 (en) 2010-10-07
WO2002034290A2 (en) 2002-05-02
WO2002034290A3 (en) 2003-03-13
WO2002034290A9 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
AU1795901A (en) "bonzo" chemokine receptor antibodies and ligands
IL201751A (en) Il-17 like cytokine binding compound and antibodies
AU2002220843A1 (en) Humanised antibodies and uses thereof
EP1110086A4 (en) Production of motif-specific and context-independent antibodies using peptide libraries as antigens
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU1290001A (en) Antibodies
HUP0100794A3 (en) Novel method for the production of anti-human antigen receptors and uses thereof
AU4314900A (en) Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU4935000A (en) Antibodies
AU2002340167A8 (en) Anti-hla-dr antibodies and the methods of using thereof
AU2001292867A1 (en) Ligands for g protein coupled receptors and methods of using them
GB9927332D0 (en) Novel antibody and uses thereof
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
AU6618100A (en) Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
AU2002228745A1 (en) Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma
AU2002305478A1 (en) Conjugates of reduced antibodies and biomolecules
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU5441000A (en) Human monoclonal antibody
AU2003260513A1 (en) Polyclonal antibodies, preparation method thereof and use of same
AUPR546801A0 (en) Recombinant antibodies
AU2002341839A1 (en) Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
AU2003299929A1 (en) System for production and screening of monoclonal antibodies
AU2003210054A1 (en) Anti-rank monoclonal antibodies and pharmaceutical composition containing the same
AU2452301A (en) Protein methylarginine-specific antibodies